Omega-3 supplementation and cardiometabolic risk factors in obese/overweight children and adolescents: a GRADE assessed systematic review and meta-analysis

Abstract Background Omega-3 polyunsaturated fatty acids (ɷ3 PUFA), have been proposed as a supplement to improve cardiometabolic risk factors in obese/overweight children and adolescents. However, findings evidence remains inconsistent. This meta-analysis aimed to assess the effects of ɷ-3 PUFA supp...

Full description

Saved in:
Bibliographic Details
Main Authors: Vali Musazadeh, Mahsa Mahmoudinezhad, Pedram Pam, Sanaz Brazandeh, Fatemeh Faramarzi, Yousef Mohammadpour, Amir Hossein Faghfouri, Shahsanam Gheibi
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Nutrition & Metabolism
Subjects:
Online Access:https://doi.org/10.1186/s12986-025-00952-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849388156146679808
author Vali Musazadeh
Mahsa Mahmoudinezhad
Pedram Pam
Sanaz Brazandeh
Fatemeh Faramarzi
Yousef Mohammadpour
Amir Hossein Faghfouri
Shahsanam Gheibi
author_facet Vali Musazadeh
Mahsa Mahmoudinezhad
Pedram Pam
Sanaz Brazandeh
Fatemeh Faramarzi
Yousef Mohammadpour
Amir Hossein Faghfouri
Shahsanam Gheibi
author_sort Vali Musazadeh
collection DOAJ
description Abstract Background Omega-3 polyunsaturated fatty acids (ɷ3 PUFA), have been proposed as a supplement to improve cardiometabolic risk factors in obese/overweight children and adolescents. However, findings evidence remains inconsistent. This meta-analysis aimed to assess the effects of ɷ-3 PUFA supplementation on cardiometabolic risk factors in obese/overweight children and adolescents. Methods A systematic review of PubMed, Embase, Scopus, Web of Science, Cochrane Library, and Google Scholar up to January 2024 was searched. Data were pooled using a random-effects model to calculate Weighted mean differences (WMDs) and 95% Confidence intervals (CIs). Results Nine studies with 595 participants were included. The meta-analysis revealed that ɷ-3 PUFA supplementation significantly reduced Body mass index (BMI) (WMD = -0.39 kg/m²; 95% CI: -0.72, -0.05, I2 = 0.0%, P = 0.497), triglyceride (TG) (WMD = -23.54 mg/dl, 95% CI: -42.90, -4.18, I2 = 89.2%, P < 0.001), and Homeostatic model assessment for insulin resistance (HOMA-IR) (WMD = -0.38, 95% CI: -0.67, -0.10, I2 = 53.6%, P = 0.071). However, ɷ-3 PUFA supplementation did not significantly affect weight, BMI-Z score, Fasting blood sugar (FBS), insulin, Total cholesterol (TC), Low-density lipoprotein- cholesterol (LDL-C), and High-density lipoprotein-cholesterol (HDL-C). Moreover, subgroup analysis elucidated that ɷ-3 supplementation has more pronounced effects in higher doses (> 1500 mg/ day) in term of BMI, LDL-c, TG. The quality of the included studies was assessed using the Cochrane risk-of-bias tool (RoB 2), which identified eight studies as having a high risk of bias. Additionally, the GRADE assessment indicated a high quality of evidence for BMI, HOMA-IR, TG and moderate quality for weight, FBS, TC, LDL-c, and HDL-c values. Conclusions The current meta-analysis revealed that ɷ3 PUFA supplementation beneficial effect on BMI, HOMA-IR, and TG levels. No favorable effect of ɷ3 PUFA supplementation on weight, BMI z-score, TC, LDL-C, HDL-C, FBS and insulin was observed.
format Article
id doaj-art-7d56ee5de74b4ec190ef19f48415caee
institution Kabale University
issn 1743-7075
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Nutrition & Metabolism
spelling doaj-art-7d56ee5de74b4ec190ef19f48415caee2025-08-20T03:42:23ZengBMCNutrition & Metabolism1743-70752025-07-0122111410.1186/s12986-025-00952-xOmega-3 supplementation and cardiometabolic risk factors in obese/overweight children and adolescents: a GRADE assessed systematic review and meta-analysisVali Musazadeh0Mahsa Mahmoudinezhad1Pedram Pam2Sanaz Brazandeh3Fatemeh Faramarzi4Yousef Mohammadpour5Amir Hossein Faghfouri6Shahsanam Gheibi7Student Research Committee, School of Public Health, Iran University of Medical SciencesStudent Research Committee, Urmia University of Medical SciencesStudent Research Committee, Urmia University of Medical SciencesStudent Research Committee, School of Public Health, Iran University of Medical SciencesMaternal and Childhood Obesity Research Center, Urmia University of Medical SciencesPatient Safety Research Center, Clinincal Research Institute, School of Medicine, Urmia University of Medical SciencesMaternal and Childhood Obesity Research Center, Urmia University of Medical SciencesMaternal and Childhood Obesity Research Center, Urmia University of Medical SciencesAbstract Background Omega-3 polyunsaturated fatty acids (ɷ3 PUFA), have been proposed as a supplement to improve cardiometabolic risk factors in obese/overweight children and adolescents. However, findings evidence remains inconsistent. This meta-analysis aimed to assess the effects of ɷ-3 PUFA supplementation on cardiometabolic risk factors in obese/overweight children and adolescents. Methods A systematic review of PubMed, Embase, Scopus, Web of Science, Cochrane Library, and Google Scholar up to January 2024 was searched. Data were pooled using a random-effects model to calculate Weighted mean differences (WMDs) and 95% Confidence intervals (CIs). Results Nine studies with 595 participants were included. The meta-analysis revealed that ɷ-3 PUFA supplementation significantly reduced Body mass index (BMI) (WMD = -0.39 kg/m²; 95% CI: -0.72, -0.05, I2 = 0.0%, P = 0.497), triglyceride (TG) (WMD = -23.54 mg/dl, 95% CI: -42.90, -4.18, I2 = 89.2%, P < 0.001), and Homeostatic model assessment for insulin resistance (HOMA-IR) (WMD = -0.38, 95% CI: -0.67, -0.10, I2 = 53.6%, P = 0.071). However, ɷ-3 PUFA supplementation did not significantly affect weight, BMI-Z score, Fasting blood sugar (FBS), insulin, Total cholesterol (TC), Low-density lipoprotein- cholesterol (LDL-C), and High-density lipoprotein-cholesterol (HDL-C). Moreover, subgroup analysis elucidated that ɷ-3 supplementation has more pronounced effects in higher doses (> 1500 mg/ day) in term of BMI, LDL-c, TG. The quality of the included studies was assessed using the Cochrane risk-of-bias tool (RoB 2), which identified eight studies as having a high risk of bias. Additionally, the GRADE assessment indicated a high quality of evidence for BMI, HOMA-IR, TG and moderate quality for weight, FBS, TC, LDL-c, and HDL-c values. Conclusions The current meta-analysis revealed that ɷ3 PUFA supplementation beneficial effect on BMI, HOMA-IR, and TG levels. No favorable effect of ɷ3 PUFA supplementation on weight, BMI z-score, TC, LDL-C, HDL-C, FBS and insulin was observed.https://doi.org/10.1186/s12986-025-00952-xOmega-3 fatty acidsDietary supplementCardiometabolic riskMeta-analysis
spellingShingle Vali Musazadeh
Mahsa Mahmoudinezhad
Pedram Pam
Sanaz Brazandeh
Fatemeh Faramarzi
Yousef Mohammadpour
Amir Hossein Faghfouri
Shahsanam Gheibi
Omega-3 supplementation and cardiometabolic risk factors in obese/overweight children and adolescents: a GRADE assessed systematic review and meta-analysis
Nutrition & Metabolism
Omega-3 fatty acids
Dietary supplement
Cardiometabolic risk
Meta-analysis
title Omega-3 supplementation and cardiometabolic risk factors in obese/overweight children and adolescents: a GRADE assessed systematic review and meta-analysis
title_full Omega-3 supplementation and cardiometabolic risk factors in obese/overweight children and adolescents: a GRADE assessed systematic review and meta-analysis
title_fullStr Omega-3 supplementation and cardiometabolic risk factors in obese/overweight children and adolescents: a GRADE assessed systematic review and meta-analysis
title_full_unstemmed Omega-3 supplementation and cardiometabolic risk factors in obese/overweight children and adolescents: a GRADE assessed systematic review and meta-analysis
title_short Omega-3 supplementation and cardiometabolic risk factors in obese/overweight children and adolescents: a GRADE assessed systematic review and meta-analysis
title_sort omega 3 supplementation and cardiometabolic risk factors in obese overweight children and adolescents a grade assessed systematic review and meta analysis
topic Omega-3 fatty acids
Dietary supplement
Cardiometabolic risk
Meta-analysis
url https://doi.org/10.1186/s12986-025-00952-x
work_keys_str_mv AT valimusazadeh omega3supplementationandcardiometabolicriskfactorsinobeseoverweightchildrenandadolescentsagradeassessedsystematicreviewandmetaanalysis
AT mahsamahmoudinezhad omega3supplementationandcardiometabolicriskfactorsinobeseoverweightchildrenandadolescentsagradeassessedsystematicreviewandmetaanalysis
AT pedrampam omega3supplementationandcardiometabolicriskfactorsinobeseoverweightchildrenandadolescentsagradeassessedsystematicreviewandmetaanalysis
AT sanazbrazandeh omega3supplementationandcardiometabolicriskfactorsinobeseoverweightchildrenandadolescentsagradeassessedsystematicreviewandmetaanalysis
AT fatemehfaramarzi omega3supplementationandcardiometabolicriskfactorsinobeseoverweightchildrenandadolescentsagradeassessedsystematicreviewandmetaanalysis
AT yousefmohammadpour omega3supplementationandcardiometabolicriskfactorsinobeseoverweightchildrenandadolescentsagradeassessedsystematicreviewandmetaanalysis
AT amirhosseinfaghfouri omega3supplementationandcardiometabolicriskfactorsinobeseoverweightchildrenandadolescentsagradeassessedsystematicreviewandmetaanalysis
AT shahsanamgheibi omega3supplementationandcardiometabolicriskfactorsinobeseoverweightchildrenandadolescentsagradeassessedsystematicreviewandmetaanalysis